Cinnamyl Alcohol
Based on 2 publication(s) in Google Scholar
Cinnamyl Alcohol is an active component from chestnut flower, inhibits increased PPARγ expression, exhibits anti-obesity, antioxidant and anti-inflammatory activities.
For research use only. We do not sell to patients.
- Purity : 98.87%
- CAS No.: 104-54-1
- Formula: C9H10O
- Molecular Weight:134.18
-
Storage:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-N0148
RutinCBR1 Inhibitor -
HY-N0610
Trans-Cinnamic acidAntibacterial Agent -
HY-Y0078R
Cinnamyl Alcohol (Standard)Analytical Standard -
HY-N0524
Propyl gallateAntioxidant -
HY-N0524R
Propyl gallate (Standard)Antioxidant -
HY-N0610R
trans-Cinnamic acid (Standard)Antibacterial Agent -
HY-N0367
Trans-AnetholeEndogenous Metabolite -
HY-N0367R
Trans-Anethole (Standard)Endogenous Metabolite -
HY-N1414
(E)-3',6-DisinapoylsucroseTrkB/BDNF Regulator -
HY-N1414R
(E)-3',6-Disinapoylsucrose (Standard)Chinese Herbal Ingredient
Publications Citing Use of MedChemExpress (MCE) Cinnamyl Alcohol
MoreAll AMPK Isoforms
More
Biological Activity
Description
In Vitro
Cinnamyl Alcohol (0.5-1 µg/µL, 24 h) inhibits LPS (HY-D1056) and IFN-γ-induced NO production in cell RAW264.7 through inhibition of iNOS[4].
Cinnamyl Alcohol (0.4-2 mM, 24 h) activates K+ channels via the NO-cGMP-PKG pathway, inhibits Rho kinase, and attenuates Phenylephrine (HY-B0769)-induced vasoconstriction in rat thoracic aorta endothelial cells[3].
Cinnamyl Alcohol (25 µM, 24-48 h) downregulates the expressions of adipogenesis-related proteins PPARγ, C/EBPα, FABP4 and adipogenesis-related proteins C/EBPβ, C/EBPδ, cyclin B1/D1/E1, and CDK2/6, arrests cell cycle at G0/G1 phase in 3T3-L1 cells, and inhibits the lipid accumulation[2].
Cinnamyl Alcohol (25 µM, 60 min) activates the AMPKα phosphorylation, inhibits AKT and ERK1/2 signaling pathway[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:3T3-L1
-
Concentration:25 µM
-
Incubation Time:16-20 h
-
Result:Downregulated expressions of PPARγ, C/EBPα, FABP4, C/EBPβ, C/EBPδ, cyclin B1/D1/E1, CDK2/6.
-
Cell Line:3T3-L1
-
Concentration:25 µM
-
Incubation Time:24-48 h
-
Result:Arrested cell cycle at G0/G1 phase.
-
Cell Line:RAW246.7
-
Concentration:0.5-1 µg/µL
-
Incubation Time:24 h
-
Result:Inhibited expression of iNOS.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mouse E. coli-induced sepsis model[5]
-
Dosage:2 g/kg
-
Administration:po, single dose
-
Result:Reduced the inflammatory reaction in the liver, heart, lungs, and kidneys
Chemical Information
-
CAS No. 104-54-1
-
Appearance Solid-Liquid Mixture
-
Molecular Weight 134.18
-
Formula C9H10O
-
Color White to light yellow
-
SMILES
OC/C=C/C1=CC=CC=C1
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
PLoS Biol
2024 Jun 27;22(6):e3002672. PMID: 38935621 -
bioRxiv
An efficient behavioral screening platform classifies natural products and other chemical cues according to their chemosensory valence in C. elegans. [Abstract]2024 Apr 3:2023.06.02.542933. PMID: 37333363
Solvent & Solubility
In Vitro:
DMSO : 200 mg/mL (1490.54 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 100 mg/mL (745.27 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 5 mg/mL (37.26 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 5 mg/mL (37.26 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (796 KB)
- English - EN (796 KB)
- Français - FR (796 KB)
- Deutsch - DE (796 KB)
- Norwegian - NO (796 KB)
- Español - ES (796 KB)
- Swedish - SV (796 KB)
- Italian - IT (796 KB)
- Korean - KR (796 KB)
- Portuguese - PT (796 KB)
-
Handling Instructions (2659 KB)
References
[1]. Hwang DI, et al. Cinnamyl Alcohol, the Bioactive Component of Chestnut Flower Absolute, Inhibits Adipocyte Differentiation in 3T3-L1 Cells by Downregulating Adipogenic Transcription Factors. Am J Chin Med. 2017;45(4):833-846. [Content Brief]
[2]. Choi YR, et al., Cinnamyl Alcohol Attenuates Adipogenesis in 3T3-L1 Cells by Arresting the Cell Cycle. Int J Mol Sci. 2024 Jan 5;25(2):693. [Content Brief]
[3]. Kang YH, et al., Cinnamyl alcohol attenuates vasoconstriction by activation of K⁺ channels via NO-cGMP-protein kinase G pathway and inhibition of Rho-kinase. Exp Mol Med. 2012 Dec 31;44(12):749-55. [Content Brief]
[5]. Zou L, et al., The anti-inflammatory effects of cinnamyl alcohol on sepsis-induced mice via the NLRP3 inflammasome pathway. Ann Transl Med. 2022 Jan;10(2):48. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 7.4527 mL | 37.2634 mL | 74.5268 mL | 186.3169 mL |
| 5 mM | 1.4905 mL | 7.4527 mL | 14.9054 mL | 37.2634 mL | |
| 10 mM | 0.7453 mL | 3.7263 mL | 7.4527 mL | 18.6317 mL | |
| 15 mM | 0.4968 mL | 2.4842 mL | 4.9685 mL | 12.4211 mL | |
| 20 mM | 0.3726 mL | 1.8632 mL | 3.7263 mL | 9.3158 mL | |
| 25 mM | 0.2981 mL | 1.4905 mL | 2.9811 mL | 7.4527 mL | |
| 30 mM | 0.2484 mL | 1.2421 mL | 2.4842 mL | 6.2106 mL | |
| 40 mM | 0.1863 mL | 0.9316 mL | 1.8632 mL | 4.6579 mL | |
| 50 mM | 0.1491 mL | 0.7453 mL | 1.4905 mL | 3.7263 mL | |
| 60 mM | 0.1242 mL | 0.6211 mL | 1.2421 mL | 3.1053 mL | |
| 80 mM | 0.0932 mL | 0.4658 mL | 0.9316 mL | 2.3290 mL | |
| 100 mM | 0.0745 mL | 0.3726 mL | 0.7453 mL | 1.8632 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Cinnamyl Alcohol Related Classifications
HY-Y0078 Related Classifications
Powered by Bioz